If you are looking for a product such as Buy Hyalgan, Surgiderm, Orthovisc, Synvisc, Sculptra, Radiesse , Hyalgan, Botox, Restylane, Orthovisc, Synvisc, Sculptra, Radiesse or Juvederm at a price lower than what we are offering on our site please contact us and we will meet or beat it.

Call us for information or a Personalized Quote.
We offer discounts for volume orders if you call!!!

Search

Cosmetic Products

Orthopaedic Products

Special Offers

News

SUFU 2007 - Urinary Frequency and Urge Urinary Incontinence in Botox™ Repeated Injections: Outcome Data Using Voiding Diaries and UDI-6 Correlation

2008-11-06

Intradetrusor Botulinum toxin type A (BTX-A) injection has emerged as a novel therapeutic option for the treatment of idiopathic overactive bladder (I-OAB) refractory to oral antimuscarinic agents. We designed an IRB approved prospective trial to evaluate the improvement in urinary frequency (UF) and urge urinary incontinence (UUI) using voiding diaries (VD), urodynamic findings, validated symptomatic improvement, and quality of life in I-OAB patients submitted to a scheduled re-injection BTX-A protocol.

For the Full Story:
http://www.urotoday.com/46/browse_categories/urinary_incontinence_ui/sufu_2007__urinary_frequency_and_urge_urinary_incontinence_in_botox_repeated_injections_outcome_data_using_voiding_diaries_and_udi6_correlation.html

<< Back

More news:

ï¿½ Vaccination rate still low for teens despite uptick (2010-09-01)

ï¿½ Drug-disposal bill gets Senate's nod (2010-08-24)

ï¿½ High cholesterol common in younger adults, but screening rates remain low (2010-08-16)

ï¿½ Patients' life circumstances an important factor in care (2010-08-12)

ï¿½ Medicaid pay commission to begin work in September (2010-08-09)

ï¿½ Verizon unveils Internet-based health information network (2010-08-06)

ï¿½ Organized medicine should take leadership role in quality, study says (2010-08-05)

ï¿½ Nixed Medicare consultation codes force doctors to make cutbacks (2010-08-02)

ï¿½ Cholesterol screening recommended for all children (2010-07-30)